Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shot aims to ease neck pain for months longer

NCT ID NCT06937931

Symptom relief Sponsor: Ipsen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 09, 2026 · Updated 7 times

Summary

This study tests a new drug, IPN10200, for adults with cervical dystonia—a condition causing painful neck muscle spasms. Current treatments last about 3 months, but IPN10200 is designed to work longer. Around 132 participants will receive either the drug or a placebo injection, and researchers will track changes in symptoms over 36 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
IPN10200 (a botulinum toxin type A injection)
What this could lead to
If it works, this could provide a longer-lasting treatment for cervical dystonia, reducing the need for injections every 3 months.
What could go wrong
This is an early Phase 2 trial with only 132 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 132 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. A clinical diagnosis of isolated Cervical Dystonia (CD) (idiopathic) characterized by dystonic symptoms localised to the head, neck, and shoulder areas with at least moderate severity at Screening and Baseline (Day 1) defined as: * (a) Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)-Total score ≥20 * (b) TWSTRS-Severity subscale score ≥15 * (c) TWSTRS-Disability subscale score ≥3 * (d) TWSTRS-Pain subscale score ≥ 1 2. Treatment naïve or non-naïve to BoNT therapy for CD Exclusion Criteria: 1. Participants presenting with a swallowing disorder of any origin which might be exacerbated by BoNT treatment, such as: * (a) Grade 3 or 4 on the Dysphagia Severity Scale (severe dysphagia) with swallowing difficulties and requiring a change in diet. 2. Predominant anterocollis. 3. Predominant retrocollis. 4. Traumatic torticollis or tardive torticollis. 5. Marked limitation on passive range of motion that suggests cervical contractures or structural abnormality.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical dystonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cervical dystonia Torticollis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical dystonia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    32 sites in 8 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Azienda USL-IRCCS di Reggio Emilia - Presidio ospedaliero provinciale sede di Reggio Emilia

    NOT_YET_RECRUITING

    Reggio Emilia, Italy

  • CHU Grenoble Alpes - Site Nord - Neurology

    RECRUITING

    Grenoble, France

  • CHU Nimes - Hôpital Caremeau

    RECRUITING

    Nîmes, France

  • Centre Hospitalier Universitaire (CHU) Purpan - Institut Des Sciences du Cerveau De Toulouse (Institute for Brain Sciences)

    RECRUITING

    Toulouse, France

  • Curiositas ad sanum Studien- und Beratungs GmbH Haag i.OB - Neurologie

    RECRUITING

    Haag in Oberbayern, Germany

  • ETG Neuroscience Sp. z o.o.

    RECRUITING

    Warsaw, Poland

  • Emory Brain Health Center

    RECRUITING

    Atlanta, Georgia, 30329, United States

  • Eskulap Pabianice Sp z o.o.

    RECRUITING

    Pabianice, Poland

  • Fakultni nemocnice Olomouc - Neurologicka klinika

    NOT_YET_RECRUITING

    Olomouc, Czechia

  • Fakultni nemocnice u sv. Anny v Brne - I. Neurologicka klinika

    RECRUITING

    Brno, Czechia

  • Futuremeds Krakow

    RECRUITING

    Krakow, Poland

  • GFO Kliniken Troisdorf

    RECRUITING

    Troisdorf, Germany

  • H.U. Puerta del Mar - Neurocirugía

    RECRUITING

    Cadiz, Spain

  • Hopitaux Universitaire de Strasbourg - Hopital de Hautepierre - Neurologie

    ACTIVE_NOT_RECRUITING

    Strasbourg, France

  • Hospital Universitario De La Princesa

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Ramon y Cajal - Neurologia

    WITHDRAWN

    Madrid, Spain

  • Hospital Universitario Virgen del Rocio - Neurofisiología Clínica

    RECRUITING

    Seville, Spain

  • Hospital de la Santa Creu i Sant Pau - Neurología

    ACTIVE_NOT_RECRUITING

    Barcelona, Spain

  • IRCCS C.Mondino, Istituto Neurologico Nazionale, Fondazione

    RECRUITING

    Pavia, Italy

  • Ichan Sch of Medicine @ Mt. Sinai

    RECRUITING

    New York, New York, 10029, United States

  • Instytut Zdrowia Dr Boczarska-Jedynak Sp. z o.o. S.K.

    RECRUITING

    Oświęcim, Poland

  • Istituto Auxologico Italiano - Auxologico San Luca

    RECRUITING

    Milan, Italy

  • Istituto Neurologico C. Besta

    ACTIVE_NOT_RECRUITING

    Milan, Italy

  • Kingfisher Cooperative

    RECRUITING

    Spokane, Washington, 99201, United States

  • Loma Linda University School of Medicine - Neurology

    WITHDRAWN

    Loma Linda, California, 92354, United States

  • Luton And Dunstable Hospital - Neurology

    ACTIVE_NOT_RECRUITING

    Luton, United Kingdom

  • MINKSneuro s.r.o.

    ACTIVE_NOT_RECRUITING

    Brno, Czechia

  • NEUROHK s.r.o.

    RECRUITING

    Choceň, Czechia

  • Ospedale Bellaria, IRCCS Istituto delle Scienze Neurologiche, AUSL Bologna

    RECRUITING

    Bologna, Italy

  • Parkinson's & Mvmt Disorders Inst

    RECRUITING

    Fountain Valley, California, 92708, United States

  • Parkinson's Ds & Mvt Disorders Cntr

    RECRUITING

    Boca Raton, Florida, 33486, United States

  • Quest Research Institute

    RECRUITING

    Farmington Hills, Michigan, 48334, United States

  • Royal Devon And Exeter Hospital - Neurology

    NOT_YET_RECRUITING

    Exeter, United Kingdom

  • Rush Medical Center

    RECRUITING

    Chicago, Illinois, 60612, United States

  • SP ZOZ Szpital Uniwersytecki w Krakowie

    RECRUITING

    Krakow, Poland

  • Specjalistyczna Praktyka Lekarska Dr Stanislaw Ochudlo

    WITHDRAWN

    Katowice, Poland

  • The Walton Centre

    RECRUITING

    Fazakerley, United Kingdom

  • Timone University Hospital

    ACTIVE_NOT_RECRUITING

    Marseille, France

  • USF Health Byrd Alzheimer's Institute

    NOT_YET_RECRUITING

    Tampa, Florida, 33613, United States

  • University College London Hospitals NHS Foundation Trust - National Hospital for Neurology and Neurosurgery

    RECRUITING

    London, United Kingdom

  • University Hospital Tuebingen - Neurologie

    ACTIVE_NOT_RECRUITING

    Tübingen, Germany

  • University of Arizona Health Sciences - Neurology

    ACTIVE_NOT_RECRUITING

    Tucson, Arizona, 85724, United States

  • Universitätsklinikum Hamburg-Eppendorf

    NOT_YET_RECRUITING

    Hamburg, Germany

  • Vseobecna fakultni nemocnice v Praze - Neurologicka klinika

    WITHDRAWN

    Prague, Czechia

  • Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego

    WITHDRAWN

    Wroclaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.